𝔖 Bobbio Scriptorium
✦   LIBER   ✦

O-033 Docetaxel (DOC), cisplatin (CIS) and gemcitabine (GEM) asneoadjuvant treatment in stage IIIAN2 and T4N0-1 non-small cell lung cancer (NSCLC) patients (P). final results of SLCG phase II trial 9901

✍ Scribed by Garrido, P.; Rosell, R.; Torres, A.; González Larriba, J.; Provencio, M.; Isla, D.; Lago, J.; Astudillo, J.; Sánchez Ronco, M.; Tarón, M.


Book ID
118572581
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
150 KB
Volume
49
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES